每周股票复盘：奥精医疗（688613）股东减持30.0万股触及1%刻度

Core Viewpoint - Aojing Medical (688613) has seen a stock price increase of 3.02% to 20.79 yuan as of December 26, 2025, with a total market capitalization of 2.848 billion yuan [1] Shareholder Changes - Beijing Qilun Tianyou Venture Capital Co., Ltd. reduced its holdings by 300,000 shares, decreasing its ownership from 6.18% to 5.96%, during a period when the stock price increased by 5.75% [2][5] - Directors Qiu Zhiye and Song Tianxi collectively reduced their holdings by 65,000 shares, while senior executive Wang Ling sold 312 shares, with the stock price rising by 9.22% and 0.76% respectively during these periods [3][5] Company Announcements - Aojing Medical announced a change in the quality control reviewer for its 2025 audit project from Shan Daxin to Wang Fang, who has been practicing since 2012 and meets independence requirements; this change will not affect the audit schedule [4][5] - The company issued a notice regarding the change in ownership of shareholders holding more than 5%, confirming that the reduction by Beijing Qilun Tianyou does not trigger a mandatory bid and complies with relevant regulations [4][5]